Figure 4From: Detection of vascular endothelial growth factor in colon cancer xenografts using bevacizumab based near infrared fluorophore conjugate Immunofluorescence staining of HT29 tumor with: (a) anti-CD 31 antibody (400×), (b) anti-VEGF-A antibody (800×), and (c) bevacizumab (800×) in frozen sections (Green: antibody labeled AlexaFluor 488, blue is DAPI). Back to article page